Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment.
about
Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersMRI contrast agents: basic chemistry and safety.Amide conjugates of the DO3A-N-(α-amino)propionate ligand: leads for stable, high relaxivity contrast agents for MRI?Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.Dy-DTPA derivatives as relaxation agents for very high field MRI: the beneficial effect of slow water exchange on the transverse relaxivities.Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging.Gd Complexes of DO3A-(Biphenyl-2,2'-bisamides) Conjugates as MRI Blood-Pool Contrast Agents.Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agentsDiffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids.The synthesis and in vitro testing of a zinc-activated MRI contrast agent.Synthesis and characterization of a novel paramagnetic macromolecular complex [Gd(TTDASQ-protamine)].A new gadolinium-based MRI zinc sensorPrimer on gadolinium chemistry.Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity.Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imagingPathophysiology of nephrogenic systemic fibrosis: A review of experimental data.A myelin-specific contrast agent for magnetic resonance imaging of myelinationThe Gd3+ complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(p-isothiocyanatoanilide) conjugated to inulin: a potential stable macromolecular contrast agent for MRI.Structure-relaxivity relationships of serum albumin targeted MRI probes based on a single amino acid Gd complex.Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.Strategies for the preparation of bifunctional gadolinium(III) chelators.A transferrin-target magnetic/fluorescent dual-mode probe significantly enhances the diagnosis of non-small cell lung cancer.New polyaminocarboxylate macrocycles containing phenolate binding units: synthesis, luminescent and relaxometric properties of their lanthanide complexes.Gadolinium-based contrast agents for magnetic resonance cancer imaging.Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review.Myelin imaging compound (MIC) enhanced magnetic resonance imaging of myelination.Gd3TCAS2: An Aquated Gd(3+)-Thiacalix[4]arene Sandwich Cluster with Extremely Slow Ligand Substitution Kinetics.Cationic gadolinium chelate for magnetic resonance imaging of cartilaginous defectsBiochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.Characterization of skin abnormalities in a mouse model of osteogenesis imperfecta using high resolution magnetic resonance imaging and Fourier transform infrared imaging spectroscopyModerate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats.Bone-seeking probes for optical and magnetic resonance imaging.The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.Target binding improves relaxivity in aptamer-gadolinium conjugates.Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model
P2860
Q28235682-5F9BCFCC-46F4-4F46-BC03-F45417F5F973Q30574482-4AE41CC3-A58E-4206-86E4-2623DB89358EQ30575277-43CF76C0-3E8B-46DF-B077-B4FCE267FD6BQ30583956-14F2A651-2FC7-4210-9D7E-EDD5218AE25AQ30604750-3BD9BC70-D55B-4181-BDA6-9D2F897A526EQ30703233-AD752F40-3D26-49A6-9976-139F453EB2E2Q30716845-50E5D255-D840-498A-BDF8-70EDA86F36DDQ30794877-2BAF8820-D604-40F8-93A0-473E8B92D1A8Q30829168-7BC2226C-7FDD-4811-A3A1-2CDEF3B0F4D3Q30830645-D40AE7B2-AD50-4E1B-B181-69BB3650F352Q30833288-509B770E-B1F1-4AE8-B40E-5EC0B08F1AADQ31122779-1D6AC26F-C6FD-4091-A228-31BF2C4634A7Q33262326-BEE6F904-3D1E-4AD6-A205-91E280B58E1DQ33486687-6104A938-5C8E-47C4-AB68-DD3D10F8AD10Q33516622-E7DE6236-6752-4FE9-8568-84018B76B8A4Q33575669-256EED53-81CF-49C7-83FC-27091DA6C2BBQ33768662-2C83D2E7-0374-43E2-B7F0-F6BAA3AC7D56Q33778292-EB56121E-847D-4C3B-BC42-FF68A2B5B669Q33803236-35C7F500-54F2-42AF-9CE3-098C5D5BB19BQ34092267-D4002DA4-BA07-4A15-A063-1292D4D90F99Q34580394-15AD0CF8-D91E-4CF3-8371-B4AB48BC4172Q35317271-C9923360-D230-441A-86EB-3A0549879C6AQ35777941-189925BF-CE19-4651-9EAC-B0E23F08E88BQ36028884-5D13F312-2E26-4A86-842F-7E49FB139F7AQ36317751-8E12762F-64FF-4ABE-BA00-6F0579813A4CQ36555415-4235F9E3-3753-418A-BF89-A671FF4240A3Q36655244-039D56A5-2A18-4024-9D94-AB351485657CQ36800158-4750A636-AFF2-46FA-AB4F-07B448F17B66Q36816753-95120447-49BE-4F7A-A808-3AE6CECBDF77Q36968430-5008D9A6-BC0F-402F-92A2-884C952F13D5Q36985258-C580F3FF-46F6-4D80-92E3-3B58AE3A55CFQ37003678-9895F67B-0AF9-42C5-AFC3-81F70EBCFDECQ37466102-63B7B868-37CF-4955-A3B7-9CC13D71A57EQ37740128-19F7CBF8-058B-48C8-8200-E43626D0AA5FQ37855914-D54265F8-B713-4B84-8006-E3BDC5E2BFD1Q38254508-5E25FEAD-2516-459B-AC03-60250EDB017DQ38322510-AE95686E-11BC-424F-9793-B1E9C0CE30F8Q38478306-EEA78E8C-F3AF-4AF9-B527-3B15BCA836E0Q38667169-72E84AEC-0A7A-416B-8865-34B51F8C45B7Q38891146-1569BCCC-A007-4611-AFD3-371F2C294F9B
P2860
Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Stability of MRI paramagnetic ...... r transmetallation assessment.
@ast
Stability of MRI paramagnetic ...... r transmetallation assessment.
@en
type
label
Stability of MRI paramagnetic ...... r transmetallation assessment.
@ast
Stability of MRI paramagnetic ...... r transmetallation assessment.
@en
prefLabel
Stability of MRI paramagnetic ...... r transmetallation assessment.
@ast
Stability of MRI paramagnetic ...... r transmetallation assessment.
@en
P2093
P1476
Stability of MRI paramagnetic ...... r transmetallation assessment.
@en
P2093
P304
P356
10.1097/00004424-200102000-00008
P577
2001-02-01T00:00:00Z